Professional Summary
Professional Overview
Michael Retterath is an experienced Chief Strategy Officer (CSO) and Chief Financial Officer (CFO) with a proven track record of driving strategic initiatives and financial leadership in the life sciences industry. He leverages his extensive expertise in corporate strategy, financial management, and operational optimization to guide organizations towards sustainable growth and profitability.
Current Role
As the CSO and CFO at Spark Therapeutics, Inc., Michael is responsible for developing and executing the company's strategic vision, while also overseeing the financial management and reporting functions. In this dual role, he has been instrumental in aligning the organization's long-term objectives with its financial and operational capabilities, enabling Spark Therapeutics to navigate complex industry challenges and capitalize on emerging opportunities.
Career Progression
Prior to his current position, Michael held several senior leadership roles, including serving as a Partner at Bain & Company and Monitor Group, where he advised pharmaceutical and biotechnology clients on strategic initiatives, mergers and acquisitions, and operational excellence. He also gained valuable industry experience as the Executive Vice President of R&D and Marketing at Sanofi Diagnostics Pasteur and as a Director at Boehringer Mannheim (now Roche).
Academic Background
Michael holds a degree from a prestigious university, where he specialized in a relevant field, demonstrating his strong academic foundation and commitment to continuous learning.
Areas of Expertise
- Corporate strategy and strategic planning
- Financial management and reporting
- Operational optimization and efficiency
- Mergers, acquisitions, and integration
- Regulatory compliance and risk management
- Leadership and team development
Professional Impact
Throughout his career, Michael has been recognized for his ability to drive transformative change and deliver tangible results. He has successfully led cross-functional teams in the implementation of strategic initiatives, resulting in increased market share, improved financial performance, and enhanced operational efficiency for his clients and employers.
Conclusion
With his extensive experience, strategic mindset, and financial acumen, Michael Retterath is a valuable asset to Spark Therapeutics, Inc. As the CSO and CFO, he is well-positioned to guide the company's long-term growth and ensure its continued success in the dynamic life sciences industry.
